Pharma has invested billions into patient services over the past decade. Call centers, hub programs, nurse educators, and enrollment teams have all been built with the same goal in mind: help patients start and stay on therapy. On paper, the infrastructure is strong. In reality, it is quietly breaking down. The issue is not effort, […]
Read more
Listen to Episode 1: Pharma’s Direct to Patient Pivot: What to Expect in 2026 here. The pharmaceutical industry is moving faster than patients can keep up. Therapies are becoming more specialized. Disease education is more complex. Access models are shifting Direct to Patient. At the same time, physician time is shrinking and patients are being […]
Read more
Enterprise pharma is moving decisively toward direct-to-patient models. This is not a marketing trend or a side project. It is a structural response to access friction, pricing pressure, and the consumerization of healthcare. Patients are behaving more like consumers, distribution models are shifting, and manufacturers are being pulled closer to the patient experience whether they […]
Read more